RE: investing in sabatoge

["Shugarman, Keith D" <KShugarman@gph.com>]

There seem to be at least two distinctions between Jamie's example and 
professor Perelman's.  

The latter ostensibly involve (i) incurring sunk/nontransferable costs to 
(ii) raise rivals' costs.


Keith D. Shugarman


______________________________ Reply Separator
_________________________________
Subject: Re: investing in sabatoge
Author:  "James Love" [SMTP:love@cptech.org] at GPH
Date:    5/29/1999 7:18 PM


A Univeristy of California researcher claims Amgen did not want to use a 
technology that would reduce by half the dose of EPO patients need. 
jamie


On Sat, 29 May 1999, Michael Perelman wrote:

> I am interested in learning about examples of corporations investing in 
> technologies to restrict the usefulness of their products.  Monsanto's 
> terminator technology, for example, makes seeds less useful to farmers. 
> I recall that IBM added circuitry to its PC Jr. to make it difficult to 
> install a second hard time.  Microsoft is accused of similar mischief. 
> --
> Michael Perelman
> Economics Department
> California State University
> Chico, CA 95929
>
> Tel. 530-898-5321
> E-Mail michael@ecst.csuchico.edu
>
>
>

-------------------------------
James Love
Center for Study of Responsive Law | Consumer Project on Technology 
P.O. Box 19367, Washington, DC 20036 | http://www.cptech.org
Voice 202/387-8030 | Fax 202/234-5176 | love@cptech.org